ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
ARGENX SE
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026
$825.61+6.47 (+0.79%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 42.2
- Dividend yield
- –
Argenx statistics
Financials through Dec 31, 2025, price-based ratios appear once a share price is available, median of Biological Products, (No Diagnostic Substances) companies for comparison
Income (trailing twelve months)
| Measure | Argenx | Industry median |
|---|---|---|
| Operating Income | $1.05B | -$21.44M |
| Pretax Income | $1.28B | -$14.45M |
| Net Income | $1.29B | -$22.46M |
| EBITDA | $1.05B | -$16.91M |
| EPS (Diluted) | $19.57 | -$0.83 |
Returns
| Measure | Argenx | Industry median |
|---|---|---|
| Return on Assets (ROA) | 17.4% | -41.0% |
| Return on Capital Employed (ROCE) | 14.3% | -37.8% |
Growth
| Measure | Argenx | Industry median |
|---|---|---|
| Net Income Growth (YoY) | 55.1% | -37.7% |
| EPS Growth (YoY) | 53.1% | -29.2% |
Balance sheet
| Measure | Argenx | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $3.49B | $62.42M |
| Net Cash (Debt) | $3.49B | $15.68M |
| Net Cash Per Share | $56.42 | $0.66 |
| Working Capital | $5.58B | $75.77M |
Financial position
| Measure | Argenx | Industry median |
|---|---|---|
| Current Ratio | 5.23 | 3.30 |
| Quick Ratio | 3.89 | 2.39 |
| Interest Coverage | 258.16 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Argenx | Industry median |
|---|---|---|
| Operating Cash Flow | $685.19M | -$12.35M |
| Capital Expenditures | -$6.17M | -$1.06M |
| Free Cash Flow | $679.03M | -$20.28M |
| FCF Per Share | $10.97 | -$0.42 |
Efficiency
| Measure | Argenx | Industry median |
|---|---|---|
| Inventory Turnover | 1.02 | 2.67 |
| Profits Per Employee | $693.52K | -$703.34K |
| Employee Count | 1,863 | 74 |
Shares
| Measure | Argenx | Industry median |
|---|---|---|
| Shares Outstanding | 61,883,300 | 58,179,650 |
| Shares Change (YoY) | 1.31% | 11.1% |
| Float | 61,883,300 | 49,173,100 |
| Shares Held by Insiders | 0.00% | 11.6% |
| Shares Held by Institutions | 45.7% | 59.4% |
Taxes
| Measure | Argenx | Industry median |
|---|---|---|
| Income Tax | -$13.43M | $91.50K |
| Effective Tax Rate | -1.05% | 20.6% |
Scores
| Measure | Argenx | Industry median |
|---|---|---|
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Argenx's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.